Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $6.7B | $6.69B | +0.18% |
Operating Income | $1.67B | $1.82B | -8.23% |
Net Income | $1.39B | $1.43B | -2.84% |
EPS (Basic) | $20.78 | $19.95 | +4.16% |
EPS (Diluted) | $20.02 | $18.68 | +7.17% |
R&D Expense | $2.75B | $2.45B | +12.28% |
SG&A Expense | $1.27B | $1.45B | -12.47% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $38.22B | $36.09B | +5.91% |
Current Assets | $16.86B | $19.08B | -11.65% |
Total Liabilities | $8.28B | $7.88B | +5.07% |
Current Liabilities | $3.67B | $3.51B | +4.51% |
Stockholders' Equity | $29.94B | $28.21B | +6.14% |
Cash & Equivalents | $2B | $1.92B | +3.91% |
Long-Term Debt | $1.99B | $1.98B | +0.08% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $2.19B | $1.87B | +17.31% |
Investing Cash Flow | $-446.5M | $-2.24B | +80.11% |
Financing Cash Flow | $-2.22B | $-431M | -414.48% |
Dividends Paid | $186.4M | $0 | — |
Share Buybacks | $2.1B | $895.2M | +134.91% |
D&A | $262M | $234.8M | +11.58% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 24.9% | 27.2% | -2.28% |
Net Margin | 20.8% | — | — |
ROE | 4.6% | — | — |
ROA | 3.6% | — | — |
Current Ratio | $4.598 | — | — |
Debt to Equity | $0.277 | — | — |
Other companies in Biotechnology